Evidence map›Paper›PMID 39618969›Full record

ArticleFrontiers in chemistry2024

UPLC-ESI/MS

Heba A S El-Nashar, Ayman M Al-Qaaneh, Md Shimul Bhuia, Raihan Chowdhury, Mostafa A Abdel-Maksoud, Hossam Ebaid, Abdul Malik, Muhammad Torequl Islam, Mohammed Aufy, Esraa A Elhawary

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Heba A S El-NasharDepartment of Pharmacognosy, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt.
Ayman M Al-QaanehDepartment of Allied Health Sciences, Al-Balqa Applied University (BAU), Al-Salt, Jordan.
Md Shimul BhuiaBioinformatics and Drug Innovation Laboratory, BioLuster Research Center, Dhaka, Bangladesh.
Raihan ChowdhuryBioinformatics and Drug Innovation Laboratory, BioLuster Research Center, Dhaka, Bangladesh.
Mostafa A Abdel-MaksoudBotany and Microbiology Department, College of Science, King Saud University, Riyadh, Saudi Arabia.
Hossam EbaidDepartment of Zoology, College of Science, King Saud University, Riyadh, Saudi Arabia.
Abdul MalikDepartment of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Muhammad Torequl IslamBioinformatics and Drug Innovation Laboratory, BioLuster Research Center, Dhaka, Bangladesh.
Mohammed AufyDepartment of Pharmaceutical Sciences, Division of Pharmacology and Toxicology, University of Vienna, Vienna, Austria.
Esraa A ElhawaryDepartment of Pharmacognosy, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The genus Materials and methods: UPLC-ESI/MS Results and discussion: The UPLC-ESI/MS Conclusion: These promising results could pave the way for a novel discovery of natural phytoconstituents with potent anti-diabetic activity.

Indexed as

anti-diabeticCedrelaphenylpropanoidsultra-performance liquid chromatography-electrospray ionization-mass spectrometryα-amylaseα-glucosidase

Identifiers

PMID39618969
PMCPMC11604428

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.